simvastatin has been researched along with 2019 Novel Coronavirus Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 7 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, M; Lee, CH; Lei, T; Monaghan-Nichols, P; Patel, PS; Qian, Y; Qiu, J; Xin, HB | 1 |
| Barreto, EA; Bou-Habib, DC; Bozza, FA; Bozza, PT; Cesar-Silva, D; Cunha-Fernandes, T; de Almeida, CJG; de Freitas, CS; Dias, SSG; Ferreira, AC; Fintelman-Rodrigues, N; Gonçalves, BS; Hottz, ED; Mattos, M; Palhinha, L; Pão, CRR; Pereira-Dutra, FS; Reis, PA; Sacramento, CQ; Saraiva, EM; Soares, VC; Souza, TML; Teixeira, L; Temerozo, JR; Viola, JPB | 1 |
| Chmielarz, M; Palko-Łabuz, A; Środa-Pomianek, K; Teisseyre, A; Uryga, A | 1 |
| Carlson, KE; Frieman, M; Furlong, B; Goyal, G; Hammond, H; Horvath, V; Ingber, DE; Kaushal, S; Kosti, I; Le, BL; Logue, J; Marić, I; Novak, R; Oskotsky, TT; Powers, RK; Prabhala, P; Rodas, M; Sirota, M; Soong, M; Sperry, MM; Stevenson, DK; Takeda, T; Wong, RJ | 1 |
| Bugarín-González, R; Figueiras, A; González-Barcala, FJ; Herdeiro, MT; Piñeiro-Lamas, M; Pintos-Rodríguez, S; Salgado-Barreira, Á; Visos-Varela, I; Zapata-Cachafeiro, M | 1 |
| Coleman, MD; Izotov, BN; Kteniadakis, S; Papadakis, GZ; Spandidos, DA; Stancioiu, F; Tsatsakis, A | 1 |
| Ahmadi, F; Ahmadi, M; Davoudi, A; Hassantabar, R; Kasgari, HA; Najafi, N; Rabiee, M; Sharifi, A; Tayebi, A | 1 |
1 review(s) available for simvastatin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
A dissection of SARS‑CoV2 with clinical implications (Review).
Topics: Amiodarone; Animals; COVID-19; Curcumin; Humans; Pioglitazone; Respiratory Distress Syndrome; SARS-CoV-2; Simvastatin | 2020 |
6 other study(ies) available for simvastatin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin.
Topics: Cell Line; Coronavirus Nucleocapsid Proteins; COVID-19; Endothelial Cells; Human Umbilical Vein Endothelial Cells; Humans; Mitogen-Activated Protein Kinases; NF-kappa B; SARS-CoV-2; Signal Transduction; Simvastatin; Toll-Like Receptor 2 | 2021 |
Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts.
Topics: Animals; COVID-19; COVID-19 Drug Treatment; Disease Models, Animal; Down-Regulation; Humans; Inflammation; Lung; Membrane Microdomains; Mice; Mice, Transgenic; SARS-CoV-2; Simvastatin; Virus Replication | 2022 |
Co-Application of Statin and Flavonoids as an Effective Strategy to Reduce the Activity of Voltage-Gated Potassium Channels Kv1.3 and Induce Apoptosis in Human Leukemic T Cell Line Jurkat.
Topics: Apoptosis; Cell Line; COVID-19; Flavonoids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kv1.3 Potassium Channel; Neoplasms; Simvastatin | 2022 |
Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patients.
Topics: Atorvastatin; Bayes Theorem; COVID-19; Drug Repositioning; Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Medical Records; SARS-CoV-2; Simvastatin | 2023 |
Outpatient atorvastatin use and severe COVID-19 outcomes: A population-based study.
Topics: Atorvastatin; Case-Control Studies; COVID-19; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Outpatients; Simvastatin | 2023 |
Studying the Effect of Taking Statins before Infection in the Severity Reduction of COVID-19 with Machine Learning.
Topics: Aged; Algorithms; Atorvastatin; COVID-19; Drug Prescriptions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Iran; Machine Learning; Male; Middle Aged; Retrospective Studies; Rosuvastatin Calcium; Severity of Illness Index; Simvastatin | 2021 |